Physician profile
Robert J Balch
NPI 1477751774
$669.34
in general payments reported to CMS, 2019-2025
16 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $14.47 · 2022: $62.80 · 2023: $40.59 · 2024: $70.92 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $138.97 | 2022-2025 | |
| Vertex Pharmaceuticals Incorporated | $84.79 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.68 | 2019-2025 | Relistor |
| Stimwave Technologies Incorporated | $45.43 | 2019 | |
| Abbott Laboratories | $44.55 | 2022-2025 | Proclaim |
| Pfizer INC. | $41.68 | 2019 | |
| Painteq LLC | $40.59 | 2023 | Painteq |
| Collegium Pharmaceutical, INC. | $38.61 | 2019 | |
| Azurity Pharmaceuticals, INC. | $38.42 | 2024-2025 | Horizant |
| Arbor Pharmaceuticals, INC. | $26.17 | 2019 | |
| Almatica Pharma LLC | $23.18 | 2022 | |
| Scilex Pharmaceuticals INC. | $22.32 | 2025 | |
| Medtronic USA, INC. | $14.70 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.47 | 2020 | |
| Valinor Pharma, LLC | $13.96 | 2025 | Movantik |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Balch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.